Thyroid dysfunction (hypothyroidism): there is concern that acetyl-L-carnitine may destroy thyroid hormones. Do not use acetyl-L-carnitine if your thyroid gland is underactive.
Acetyl-L-carnitine (ALC) is a modified amino acid that supports cellular energy generation by assisting in the transport of fats to mitochondria where they are converted to ATP (cellular fuel).ALC helps steer oxidative damage and support mitochondrial function and normal neurotransmitter It is a fairly organically available carnitine with the ability to overcome the blood-brain barrier to help maintain output. Clinical studies have shown that ALC helps maintain proper neurological health.
Take 1-2 doses once or twice daily as needed.
What is acetyl-L-carnitine?
- 1 What is acetyl-L-carnitine?
- 2 Outstanding Properties and Benefits of Acetyl-L-Carnitine
- 2. 1 Cognitive Amplification
- 2. 2 Effective Neuroprotector
- 2. 3 Possible treatments for old-AGE related disorders
- 2. 4 analgesics
- 2. 5 Healing depression and fatigue
- 3. 1 Scale up neurotransmitter production by weight
- 3. 2 Brain metabolism and neuroprotection building
- 3. 3 Other effects in the body
- 5. 1 ALCAR and Piracetam stack.
- 5. 2 ALCAR and MIND LAB PRO Stack.
Acetyl-L-Carnitine (ALCAR) is a micronutrient in natural quantities that guarantees the macrocentery of the human brain and body. Not enough to be a powerful psychotropic with the ability to increase focal confinement [1] and §[2] ALCAR is also considered a huge neuroprotector that fights physiological and intellectual lethargy, §[3] promotes mental and vascular wells, helps defense against the test of time. §[5].
Alkar is considered a lysine derivative L-carnitine, which is naturally produced by the body but can also be synthesized from animal proteins on the menu, but is quite organically available.
Unlike other forms of L-carnitine, it functions in an important way in the body and is commonly used to enhance physiological performance and promote blood flow issues. 6].
Alkar is considered a precursor to the “leather neurotransmitter” acetylcholine [7], making it a valuable psychotropic substance. In addition, studies have shown that it affects brain energy metabolism by increasing noradrenaline and serotonin and lowering the inhibitory neurotransmitter GABA [8].
It has also been shown to function in brain cells themselves by helping to maintain the unity of cellular mitochondria, the cell’s “power plant” where calories are converted into energy. Age-related shifts to poorer mitochondria have been associated with a variety of conditions, including Alzheimer’s disease and other neurodegenerative disorders.
Alcor is available as a dietary supplement without a prescription.
Interactions.
Moderate Interactions.
Beware of this combination.
Acenocoumarol (Sintrom) leads to an interaction with acetyl-L-carnitine
Warfarin (Coumadin) has an interaction with acetyl-L-carnitine
Serotonin agonists have interactions with acetyl-L-carnitine
Thyroid hormones have an interaction with acetyl-L-carnitine
Acetyl-L-carnitine was most frequently used by adults in doses of 1, 5-3 g per day, in the direction of 33 months. Consult your health care provider to find out which dose is most appropriate for your particular condition.
Used literature:
Balercia, G., Regoli, F., Armeni, T., Koverech, A., Mantero, F., and Boscaro, M. Placeboge-controlled double-blind randomized study on the use of L-carnitine, L-acetylcarnitine, or combination idiopathic of L-carnitine and L-acetylcarnitine in men with athenosomiasis. Fertility. steril. 2005; 84(3):662-671. view abstract
Cai, T., Wagenlehner, F. M., Mazzoli, S., Meacci, F., Mondaini, N., Nesi, G., Tiscione, D., Malossini, G. and Bartoletti, R. Phytotherapeutic drugs. J Androl 2012; 33(4): 615-623. abstract.
Cavallini, G., Ferraretti, A. P., Gianaroroli, L., Biagiotti, G., and Vitali, G. Cinnoxicam and L-carnitine/acetyl-L-carnitine healing idiopathy and associated varicose veins. J Androl 2004; 25(5):761-770.
Cheng, H. J., Chen, T., Zhonghua Nan. ke. xue. 2008; 14(2):149-151. view abstract
Malaguarnera, M., Bella, R., Vacante, M., Giordano, M., Malaguarnera, G., Gargante, M. P., Motta, M., Mistretta, A., Rampello, L. and Pennisi, G. Acetyl – L-carnitine decreases depression and improves quality of life in patients with small rebasepathies. Skans. j Gastroenterol. 2011; 46(6):750-759. abstract.
Malaguarnera, M., Gargante, M. P., Cristaldi, E., Colonna, V., Messano, M., Koverech, A., Neri, S., Vacant, M., Cammalleri, L., and Asetull L-Anemic old carnitine (ALC) treatment in patients. Arch. Gerontol. geriatr. 2008; 46(2):181-190. summary.
Malaguarnera, M., Vacante, M., Giordano, M., Pennisi, G., Bella, R., Rampello, L., Li, Volti G. and Galvano, F. Clear hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Am. JClin. Nutr. 2011; 93(4):799-8 08. See summary.
Malaguarnera, M., Vacante, M., Motta, M., Giordano, M., Malaguarnera, G., Bella, R., Nunnari, G., Rampello, L., and Pennisi, G. Acetyl-L-carnitine acetyl-L carnitine improves cognitive function with difficult delivery selection: a randomized and controlled clinical study.Metab Brain Dis 2011; 26(4):281-289. view abstract
Morgante, G., Scolaro, V., Tosti, C., Di, Sabatino A., Piomboni, P., De, Leo, V. [Carnitine Treatent, acetyl Carnitine, L-arginine, and ginseng better guarantee spermatogenesis and sexual well-being in men with asenospermia. Minervalol. nefrol. 2010; 62(3): 213-218. view abstract
Youle, M., and Osio, M. Double-blind, parallel-group, placebo-controlled, multicenter study of of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in HIV-1 infected patients. hiv. mfa. 2007; 8(4):241-250. view abstract
12761 Benvenga S, Amato A, Calvani M, Trimarchi F. Effect of carnitine on thyroid hormone exposure. Ann n y Acad Sci 2004; 1033: 158-67. Show summary.
Abbasi S, Heidari S, Mohammadi MR, Tabrizi M, Galeiha A, Ahondzadeh S. Acetyl-L-carnitine as an add-on therapy in the treatment of attention deficit/hyperactivity disorder in boys and young adults: a placebo-controlled A study. Child Psychiatry Hum Development. 2011 Jun; 42(3):367-75. abstract.
Anon. Carnitor (Levocarnitine) package leaflet. Sigma-Tau Pharmaceuticals Inc, Gaithersburg, MD. 1999 Dec.
Bachmann Hu, Hoffmann A. Interaction of L-carnitine supplementation with oral anticoagulant adenomas. swiss Med Wly 2004; 134: 385.
Baek SM, Zheng R, Seo EJ, Hwang DY, Kim BH. pharmacokinetic comparison or two forms of acetyl-L-carnitine in healthy Korean volunteers. Int J Clin Pharmacol Ther. 2015; 53(11): 980-6. view abstract
Barditch-Crovo P, Toot J, Hendrix CW, et al. Microbial activity, protection, and pharmacokinetics of adefovir-dipivoxil (9- [Bis-Pivaloyloxymethyl)-phosphylmethyl patients). Infect Dis 1997; 176:406-13. abstract.
Beghi E, Pupupillo E, Bonito V, Buzzi P, Caponnetto C, ChioòA, Corbo M, Giannini F, Ingrilleri M, Bella VL, Logroscino G, Lorusso L, Lunetta C, Mazzini L, Messina P, Mora G, Perini M , L, Lunetta C, Massina P, Mora G, Perini M Quadrelli ML, Silani V, Simone IL, Tremolizzo l; Italian as study group. a randomized, double-blind, placebo-controlled study on acetyl-L-carnitine in ALS. Myxomatous hair circle cler frontotemporal regression machine. 2013 Sep; 14(5-6):397-405. abstract.
Bella R, Biondi R, Raffaele R, Pennisi G. Effect of acetyl-L-carnitine on aging patients suffering from discomfort disorders. Int J Clin Pharmacol Res 1990; 10: 355-60. view abstract
Benvenenga S, Ruggeri RM, Russo A, et al. Usefulness or L-carnitine, natural peripheral antagonist or thyroid hormone exposure, and hyperthyroidism: a randomized, double-blind, placebo-controlled clinical J Clin Endocrinol Metab 2001; 86: 3579-94. Show summary.
Biagiotti G, Cavallini G. Acetyl-L-carnitine and tamoxifen in the oral therapy of Peyronie’s disease: a preparatory report. bju int 2001; 88: 63-7. view abstract
Bidzinska B, Petraglia F, Angioni S, et al. Effects of omnipotent intermittent stressor and acetyl-L-carnitine on hypothalamic beta-endorphin and GNRH and plasma testosterone levels in male rats. neuroendocrinology 1993; 57: 985-90. abstract.
Brass EP. pätels-human prodrugs and carnitine produce homeostasis. pharmacol Rev 2002; 54: 589-98. abstract view.
Brennan B. P., Jensen JE, Hudson G, Coit KE, Bowliw A., Pope HGJR, Renshaw PF, Cohen B. J Clin Psychopharmacol. 2013 Oct; 33(5):627-35. show abstract
Brooks JO 3rd, Yes, Carta A, Bravi D. Acetylcarnitine slows down in young patients with Alzheimer’s disease: secondary to a double-blind placebo-controlled study by shaking design. Int Psychoger 1998; 10: 193-203. Show summary
Bruno A, Pandolfo G, Crucitti M, Lorusso S, Zoccali RA, Mascatello MR, Zoccali R. Clin Neuropharmacol. 2016; 39(6): 277-80. view instructions
Callander N., Markovina S., Eickhoff J., Hutson P., Campbell T., Hematti P., Goh R., Hegman R., Longo V., Williams E., Asimakopoulos F., Miyamoto S. Acetyl-L-carnitine (ALCAR) chemotherapy propylaxis-induced peripheral neuropathy in patients with flexural or shock-tolerant multiple myeloma treated with bortezomib, doxorubicininoma, doxorubicinin, and low-dose dexamethasone: a Wisconsin Oncology Network Study. Cancer Chemopharm. 2014 Oct; 74(4):875-82. bekijk Summary.
Campone M, Berton-Rigaud D, Joly-Lobbedez F, Baurain JF, Rolland F, Stenzl A, Fabbro M, Van Dijk M, Pinkert J, Schmelter T, De Bont N, Pautier P Sagopyrone-induced peripheral acetyl-L-carnitine in the prevention of neuropathy. Oncology. 2013; 18(11):1190-1. Bekijk Summary.
Campos Y, Arenas J. Muscle carnitine deficiency associated with zidovudine-induced mitochondrial myopathy.Ann Neurol 1994; 36: 680-1. Bekijk Summary.
Castro-Gago M, Eiris-Punal J, Novo-Rodriguez MI, et al. Serum carnitine levels in children with epilepsy before and during treatment with valproic acid, carbamazepine, and phenobarbital. J Child Neurol 1998; 13: 546-9. Bekijk Summary.
Cavallini G, Caracciolo S, Vitali G, et al. Androgeenafhankelijke carnitine-ganging in genezing van seksuele disfunctie de genezing, tempressive Urologie 2004; 63: 641-6. Bekijk Summary.
Coulter DL. carnitine, valproaat en toxicatiteit. j Child Neurol 1991; 6: 7-14. Bekijk Geabstraheerd.
Coulter DL. Prevention of recurrent hepatotoxicity by valproic acid and carnitine monotherapy. ann Neurol 1988; 24: 301.
Cucinotta D, Passeri M, Ventura S, et al. A multicenter clinical placebo-controlled study using acetyl-L-carnitine (ALC) in the treatment of slightly reckless elderly persons. depluart Development Res 1988; 14: 213-6.
Curran MWT, Morhart MJ, Olson JL, Hachisuka A, Chan KM. Acetyl-L-carnitine to promote nerve regeneration in carpal tunnel syndrome: a double-blind randomized controlled trial. Plastriconstosj. 2019 Jan; 143(1):111E-120E. bekijk Summary.
Dalakas MC, Leon-Monzon ME, Bernardini I, et al. zidovudine-geïnduceerdemitochondriale myopathie spiercarnitine in lipid dispersion deficiëntieentieficiëntie acquired. ann Neurol 1994; 35: 482-7. Bekijk Summary.
De Grandis D, Minardi C. Acetyl-L-carnitine (levacecarnine) in the Van Diabetische Neuropathie de Behandeling. een Gerandomiseerde, Dubbelblinde, Placebogecontroleerde Studie op Lange Termijn. substance R D 2002; 3: 223-31. Bekijk Summary.
Vivo DC, Bohan TP, Coulter DL, etal. l-carnitine supplementation for L-carnitine supplementation: current options. Graves 1998; 39: 1216-25. view abstract
Deeks SG, Collier A, Lalezari J, et al. Protection and efficacy of Adefovir Dipivoxil in the general population of immunocompromised microbial opiods (HIV), HIV-infected mature adults: randomized double-bovine-bo – blinded – brand blind blind blinded
Di Marzio L, Moretti S, D’Alo S, et al. Acetyl-L-carnitine intrusion increases insulin-like uptake factor 1 values in asymptomatic HIV-1 subjects Clin Immunol 1999; 92: 103-10. Show summary.
Evans AM, Fornasini G. Pharmacokinetics of L-carnitine. Clin Pharmacokinet 2003; 42: 941-67. view abstract
Famularo G, Moretti S, Marcellini S, et al. Acetylcarnitine deficiency in AIDS patients with neurotoxic door sclerosis or antiretroviral nucleoside analogues. AIDS 1997; 11: 185-90. view abstract
Freeman JM, Vining EPG, Price S, Singhi P. Double-blind crossover study.Pediatrics 1994; 93: 893-5. Show abstract.
Garzya G, Corallo D, Fiore A, et al. Evaluation of the effects of L-acetylcarnitine on elderly depressed patients. Medica Exp Clin Res 1990; 16: 101-6. view abstract
Georgala S, Schulpis KH, Georgala C, Michas T. La-Carnitine supplementation on isotretinoin therapy in patients with cystic acne. J EUR Acad Dermatol Venereol 1999; 13: 205-9. view abstract
Georges B, Galland S, Rigaud S, et al. Necessary effects of L-carnitine in C2C12 myoblasts. Interaction with zidovudine. Biochem Pharmacol 2003; 65:1483-8. …. Summary.
Golan R, Weissenberg R, Levine LM Carnitine and Acetyl Carnitine in Motile and Imobile Human Sperm. Int J Androl 1984; 7: 484-94. view abstract
Goodison G, Overeem K, Monte V, Siskind D. Mania associated with autonomous registration of acetyl-L-carnitine in men with bipolar I disorder. Australian Psychiatry. 2017; 25(1):13-4. abstract.
Hart A. M., Wilson A. D., Montovani S., et al. Acetyl-L-carnitine: on etiology-based healing in HIV-related antiretroviral toxic neuropathy. Speed 2004; 18: 1549-60. view abstract
Hershman DL, Unger JM, Crew KD, et al. Two-year trends in taxane-induced neuropathy in women enrolled in a randomized study of acetyl-L-carnitine (SWOG S0715). J Natl Cancer Inst. 2018; 110(6): 669-676. bekijk Summary.
Hershman DL, Unger JM, Crew KD, Minasian LM, Awad D, Moinpour CM, Hansen L, Lew DL, Greenlee H, Fehrenbacher L, Wade JL 3r d-Y, Wong SF, Hortobagyi GN, Meyskens FL, Albain KS. a randomized double-blind controlled study of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women receiving adjuvant therapy for breast cancer. J Clin Oncol. 2013¡10 Jul; 31(20): 2627-33. Bekijk Summary.
Heuberger W, Berardi S, Jacky E, et al. Accumulation of urinary carnitine excretion in patients treated with cisplatin. Eur J Clin Pharmacol 1998; 54: 503-8. Bekijk Summary.
Hirose S, Mitsudome A, Yasumoto S, et al. Valproic acid therapy does not deplete carnitine levels in healthy children. Kindergarten 1998; 101:E9 (summary). bekijk Summary.
Holme E, Greter J, Jacobson CE, et al. Carnitine deficiency induced by pivampicillin and pivmecillinam therapy. Lancet 1989; 2: 469-73. bekijk Summary.
Hudson S, Thabet N. Acetyl-L-carnitine voor Dementie. Cochrane Database Syst Rev 2003; 2:CD003158. Bekijk Summary.
Hug G, McGraw CA, Bates SR, et al. Decreased serum carnitine concentrations during anticonvulsant therapy with phenobarbital, valproic acid, phenytoin, and carbamazepine support. J Pediatr 1991; 119:799-802.
Jeulin C, Lewin LM. Role of free L-carnitine and acetyl-L-carnitine in mammalian sperm postgonadal maturation. Hum Reprod Update 1996; 2:87-102.
Jeulin C, Soufir JC, Marson J, et al. [Acetylcarnitine and sperm: association with epididymal maturation and motility in wild boar and man]. Reprod nutr Development 1988; 28:1317-27. Bekijk Summary.
Jiang Q, Jiang G, Shi KK, Cai H, Wang YX, Zheng MH. oral acetyl-L-carnitine treatment in hepatic encephalopathy: an evidence-based view of medicine. Ann Hepatol. 2013 SEP-OCT; 12(5):803-9. een afgeleide menier.
Kahn J, Lagakos S, Wolfson M, et al. werkzaamheid en veiligheid van adefovir dipivoxil filled antiretroviral therapy. j Am Med Assoc 1999; 282:2305-12. bekijk Summary.
Kano M., Kawakam T., Hori H., et al. Effect of algae on acute axonal motor transport in cultured sensory neurons of streptozotocin-induced diabetic rats. Neurosci Res 1999; 33: 207-13. Bekijk Summary.
Koengkul S, Tanphaichitr V, Muangmun V, Tanphaichitr N. Importance of L-carnitine and L-O-ocetylcarnitine in normal and sterile human semen: greater L-O-A-acetylcarnitine in sterile semen.Fertil Steril 1977; 28:1333-6. abstract.
Krahenbuhl S, Reichen J. Carnitine metabolism in patients with cerebral liver disease. Hepatology 1997; 25: 148-53. view abstract
Krahenbuhl S. Carnitine metabolism in posterior weak liver disease.Life Sci 1996; 59:1579-99. overview.
Kurul S, Dirik E, Iskan A. Importance of serum carnitine duration oxcarbazepine and carbamazepine monotherapy in boys with epilepsy. J Child Neurol 2003; 18: 552-4. view abstract.
Lai CL, Ahn SH, Lee KS, Um Sho M, Yoon S. K, Lee JW, Park NH, Kweon Y, Song JH, Lee J, Kim JA, Han KH, Yuen MF Bezifovir from the multiventricular randomized Phase IIB study (LB80380) in Asian patients with encephalitis Entekavir and the enteroenteromuscular tract in. 2014 Jun. 63(6):996-1004. abstract.
Leiker MF, Green S, Bhuyan A. K., Schuster S. Isotretinoin and serum lipids: fatty acids, apolipoproteins and intermediary metabolism studies. Br J Dermatol 1987; 117: 203-6. view abstract
Ledinek A. H., Sayko M. K., Yedok U. Evaluation of the effects of amantadine, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis outcomes in a pilot randomized bound study. Clin Neurol Neurosurg. 2013 Dec; 115 Supplement 1:S86-9. abstract.
Lenzi A, Sgro P, Salacone P, et al. l-carnitine Healing with L-acetylcarnitine in men with asthenozoosclerosis Fertil Steril 2004; 81: 1578-84. view abstract
Leombruni P, Miniotti M, Colonna F, Sica S, Castelli L, Bruzzone M, Parisi S, Fusaro E, Sarzi-Puttini P, Aceni F, Tortica R G. and acetyl L-carnitine in fibromyalgia patients: preparation data. Clin Exp Rheumatol. jan-feb 2015; 33(1 Suppl 88):S82-5. view abstract
Li S, Chen X, Li Q, et al. Effects of acetyl-L-carnitine and methylcobalamin in diabetic peripheral neuropathy: a multineutral randomized double-blind controlled study. j Diabetes Res. 2016; 7(5): 777-85. abstract.
Liu J., Head E., Kuratsune H., et al. Comparison of the effects of L-carnitine and acetyl-L-carnitine on carnitine degree, mobility vitality, and biomarkers of oxidative stress in aged rat brain. Ann, New York, Academy of Sciences, 2004. 1033:117-31. abstract.
Lo Jiudice P, Careddu A, Magni G, et al. Independent neuropathy in streptozotocin-diabetic rats: effects of acetyl-L-carnitine. Diabetes 2002; CLIN PRACT; 56: 173-80. abstract.
Loprinzi CL, Lacketti C, Bleeker J, et al. J Clin Oncol 2020; 38(28): 3325-48. view abstract
Marthaler NP, Visarius T, Kupfer A, Lauterburg BH. structure of urinary carnitine cost during Ifosfamide chemotherapy.Cancer CheTher Pharmacol 1999; 44: 170-2. Show summary.
Martí-Carvajal AJ, Gluud C, Arevalo-Rodriguez I, Martí-Amarista CE. acetyl-L-carnitine in patients with hepatic encephalopathy. Cochrane Basic Cyst Rev. 2019 Jan 5; 1: CD011451. doi: 10. 1002/14651858. cd011451. pub2. abstract.
Martínez E, Domingo P, Roca-Cusachs A. Potential effects of acinocoumarol with L-carnitine support. j Mid 1993; 233:94.
Martinotti G, Andreoli S, Reina D, Di Nicola M, Ortolani I, Tedeschi D, Fanella F, Pozzi G, Iannoni E, D’Dio S, Dr. L. J. Melancholic and adverse characteristics in alcohol dependent subjects Acetyl-L-carnitine in the treatment of. Prog Neuropsychopharmacol Organic Psychiatry. 2011 Jun; 35(4):953-8. abstract.
Martinotti G, Reina D, Di Nicola M, Andreoli S, Tedeschi D, Ortolani I, Pozzi G, Iannoni E, D’Dio S, Gianiri L., Double-blind placebo controlled pilot test. Alcohol Alcohol. 2010 SEP-OCT; 45(5):449-55. view abstract
Maye R, Sano M. Healing Alzheimer’s disease. n Engl J 1999 Mid; 341: 1670-9.
Memeo A., Loero M. Thioctic acid and acetyl-L-carnitine in the treatment of sciatica caa by herniated disc: a randomized double-blind comparative study. Clin Drug Investument 2008; 28(8): 495-500. view abstract
MICICIC S, LALIC N, JORDJEVIC D, et al. Double-blind randomized placebo-controlled study on the effects of L-carnitine and L-acetylcarnitine on sperm characteristics in men with idiopathic oligoasthenozoospermia. andrologia 2019; 51(6):e13267. doi: 10. 1111/□. 13267. See summary.
Minn Rhone G. Carnitine in diabetes mellitus 2 in a similar manner. ann n y Acad Sci 2004; 1033: 99-107. distracting view.
Mintz M. Carnitine in human immunodeficiency microorganism infection pattern 1 infection/ acquired immune deficiency syndrome. j Child Neurol 1995; 10: S40-4. view abstract
Moncada ML, Vicari E, Cimino C, et al. Effect of acetylcarnitine on healing in patients with oligoasthenospermia. Acta Europ Fertil 1992; 23: 221-4. view abstract
Montgomery SA, Tal LJ, Amrein R. Meta-analysis of double-blind randomized clinical studies of acetyl-L-carnitine versus placebo in the healing of non-pure cognitive impairment and non-potent Alzheimer’s disease. Int Clin Psychopharmacol 2003; 18: 61-71. Show summary.
Noble S, Gore KL. Adefovir Dipivoxil. drugs 1999; 58: 479-87. view abstract
Onofrj M, Fulgente T, Melchionda D, etal. L-acetylcarnitine as a new therapeutic application to troublesome painful peripheral neuropathy. Int J Clin Pharmacol Res 1995; 15:9-15. view abstract
Opala G, Winter S, Vance C, et al. Effect of valproic acid on plasma carnitine levels. Am J Dis Child 1991; 145: 999-1001. Show summary.
Palmero S, Leone M, Prati M, et al. Effects of L-acetylcarnitine on some reproductive functions in oligoastenospermic rats. Horm Metab Res 1990; 22:622-6. Show summary.
Parvanova A, Trillini M, PodestàMA, et al. Groovy pressure and metabolic effects of acetyl-L-carnitine in diabetes mellitus 2 in tumor 2: a randomized controlled diabasi study. J Endocrity Soc. 2018; 2(5): 420-436. display abstract Subjects.
Passeri M, Cucinotta D, Bonati PA, et al. Int J Clin Pharmacol Res 1990; 10: 75-9. abstract View abstract
Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer’s disease.Neurobiol Aging 1995; 16:1-4. view abstract
Pettegrew JW, Levine J, McClure RJ. Physiological chemistry, metabolism and therapeutic quality of acetyl-L-carnitine: relevance of its mode of action in Alzheimer’s disease and senile depression. Mol Psychiatry 2000; 5: 616-32. view abstract
Pisano C, Pratesi G, Laccabue D, et al. Clin Cancer Res 2003; 9: 5756-67. Show summary.
Pop Busi R, Marinescu V, van Huysen C, et al. Metabolic, vascular and nerve conduction interrelationships in experimental diabetic neuropathy supported by cyclooxygenase inhibition and acetyl-L-carnitine intrusion. Diabetes 2002; 51: 2619-28. view abstract
Postiglione A, Soricelli A, Cicerano U, et al. Pharmacol Res 1991; 23:241-6. view abstract
Quatraro A, Roca P, Donzella C, et al. Acetyl-L-carnitine in symptomatic diabetic neuropathy.Diabetologia 1995; 38:123.
Rai G, Wright G, Scott L, et al. A double-blind, placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer’s disease.Curr Med Res Mind 1990; 11: 638-47. view abstract
Raskind JY, El-Chaar G M. The role of carnitine supplementation period valproate therapy. Ann Pharmacother 2000; 34: 630-8. Show summary.
Raskind JY, El-Chaar G M. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. cj. Ann n y Acad Sci 2004; 1033:30-41. view abstract
Riva R, Albani F, Gobbi G, et al. Grapevine Disease 1993; 34: 184-7. view abstract
Rolim LC, Da Silva EM, Flumignan RL, Abreu MM, Dib SA. acetyl-L-carnitine for healing diabetic peripheral neuropathy. Cochrane Data Basic Syst Rev 2019 Jun 15. 6: CD011265. doi: 10. 1002 /14651858. cd011265. pub2. abstract.
Rosadini G, Marenco S, Nobili F, et al. Acute effects of acetyl-L-carnitine on regional cerebral blood flow in patients with cerebral ischemia.Int J Clin Pharmacol Res 1990; 10: 123-8. view abstract
Rossini M, Di Munno O, Valentini G, Bianchi G, Biasi G, Cacace E, Malesci D, La Montagna G, Viapiana O, Adami S. acetyl l-carnitine Use of placebo in the treatment of patients with fibromyalgia. Clinical Exple Haumatol. 2007 Mar-APR; 25(2):182-8. abstract.
Salvioli G, Neri M. l-Acetylcarnitine cures psychological depression in old people. Drugs Exp Clin Res 1994; 20: 169-76. view abstract
Sano M, Bell K, Cote L, et al. of acetyl Levocarnitine in patients with Alzheimer’s disease. Arch Neurol 1992; 49: 1137-41. view abstract
Scarpini E, Sacilotto G, Baron P, et al. Effect of acetyl-L-carnitine on healing of peripheral neuropathy in HIV+ patients. J Peripher Never Syst 1997; 2:250-2. Display abstract.
Schlenzig JS, Charpentier C, Rabier D, etal. L-Carnitine: a method to inhibit Ifosfamide cytotoxicity Eur J Pediar 1995; 154: 686-7. Show summary
Sekas G, Paul HS. Pyramondemia and carnitine deficiency in patients treated with sulfadiazine and pyrimethamine. Am J Med 1993; 95: 112-3.
Shapira Y, Gutman A. Muscle carnitine deficiency in patients treated with valproic acid. J Pediatrics 1991; 118:646-9. abstract view.
Sheetz MJ, King GL. Molecular recognition of the side effects of hyperglycemia on diabetes exacerbation. Jama 2002; 288: 2579-88. view abstract
Sima Aaf, Calvani M, Mehra M, et al. Acetyl-L-carnitine improves pain, nerve regeneration, and vibration perception in patients with acquired diabetic neuropathy: examination of two randomized placebo-controlled studies. Diabetes Care 2005; 28: 89-94. view abstract
Spagnoli A, Lucca U, Menasce G, et al. Long-term healing with acetyl-L-carnitine in Alzheimer’s disease.Neurology 1991; 41: 1726-32. view abstract
Stanley K. Carnitine deficiency disorder in a boy with disability. Ann n y Acad Sci 2004; 1033: 42-51. abstract view.
Suzuki H, Hibino H, Inoue Y, Mikami A, Matsumoto H, Mikami K. Effects of acetyl-L-carnitine in an older patient with valcut invasive sodium-related hyperantibodymia. Asian j Psychiatry. 2017; 30: 179. abstract view.
Suzuki H, Hibino H, Inoue Y, Mikami K. Superior quality or concurrent use or antidepressants and acetyl-L-carnitine in the treatment of moderate depression. Asian j Psychiatry. 2017¡ Oct 23. [Epub outweighs the pressure]. Abstract View.
Szymanski M, Wandtke T, Washilow K, Andryszczyk M, Janicki R, Domaracki P. Comparison of oral fumarate and acetyl-L-carnitine combinations in antidepressant-incordant sterility or 3-month and 6-month results. am J Mens Health 2021; 15(5):1557983211036790. see abstract.
Tamamogullari N, Silig Y, Icagasioglu S, Atalay A. Carnitine deficiency in sweet diabetic complications.J Diabetes Ocledations 1999; 13: 251-3. View Abstract
Tanphaichitr N. In vitro stimulation of human sperm motility by acetylcarnitine. Int J Fertil 1977; 22: 85-91. Show summary.
Tauqir S, Israr M, Rauf B, et al. Acetyl-L-carnitine improves the metabolic and endocrine composition of women with PCOS. A double-blind clinical study.Adv Ther 2021; 38(7):3842-3856. abstract.
Tempesta E, Casella L, Pirrongelli C, etal. L-acetylcarnitine in depressed elderly subjects. A placebo contralateral crossover study. Med Expel Clin Res 1987; 13: 417-23. view abstract
Tempesta E, Troncon R, Janiri L, et al. Int J Clin Pharmacol Res 1990; 10: 101-7. view abstract
Thal LJ, Carta A, Clarke WR, et al. A one-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer’s disease Neurology 1996; 47: 705-11. display abstract
H, Carter PE, Cole GF, et al. Ammonia and Carnitine concentrations in children treated with Valcate sodium compared with other anticonvulsant products.Dev Med Child Neurol 1991; 33: 795-802. Show summary.
Torrioli MG, Vernacotolas A, Mariotti P, et al. A double-blind, placebo-controlled study of L-acetylcarnitine on curing overactive behavior in the fragile X syndrome Am J Med Genet 1999; 87: 366-8.
Torrioli MG, Vernacotolas A, Peruzzi L, et al. Double-blind, L-acetylcarnitine-placebo parallel, polycentric comparison of hyperactivity in boys with fragile X syndrome of no interest. Am J Med Genet A. 2008; 146a(7):803-12. Show summary Abstruct.
Tsoko M, Beauseigneur F, Gresti J, et al. Improved vitality against fatty acid oxidation in the liver of L-carnitine depleted rats in favor of D-carnitine and gamma-butyrothin hydroxylase inhibitors Biochem Pharmacol 1995; 49: 1403-10. abstract.
From Nuwe JP. Carnitine depletion during valproic acid treatment.Int J Vitam Nutr Res 1995; 65: 211-4. abstract view.
Vance KK, Vance H, Winter SK, et al. Ann Neurol 1989; 26: 456.
Vermeulen RC, Scholte HR. a randomized, labeled, randomized study of acetyl and propionylcarnitine in stroke syndromes disclosed. psychosom Med 2004; 66: 276-82. display abstract.
Veronese N, Stubbs B, Solmi M, Ajnakina O, Carvalho AF, Maggi S. Acetyl-L-carnitine supplementation and healing of signs of depression: a periodic review and meta-analysis. Psychosom Med. 2018; 80(2): 154-9. view abstract
Vicari E, La Vignera S, Calogero AE. antioxidant healing with carnitine is effective in patients with infertile prostatic preputial osteoarthritis and increased mental leukocyte concentration after healing with NSAIDs. Fertil Steril 2002; 78:1203-8. …. Summary.
Vidal-Casariego A, Burgos-PeláezR, Martínez-Faedo C, Calvo-Gracia F, Valero-ZanuyMá, Luengo-PérezLM, Cuerda-CompésC. metabolic effects of L-carnitine on diabetic mellitus: Routine and leisure LDL and normal LDL. meta-analysis. Ex Endocrinol Diabetes. 2013 Apr; 121(4):234-8. abstract.
Wang DD, Wang Ty, Yang Y, S M, Wang Im. Effects of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine on body weight in sweet diabetic patients on concordance. front Nutr 2021; 8: 748075. view abstract.
Wei G, Zhou Z, Cui Y, et al. Meta-analysis of L-carnitine/L-acetylcarnitine or N-acetylcysteine function in men with idiopathic acenosomiasis. Am J Mens Health 2021; 15(2):155798321101111371. abstract. See.
Winter SC, Szabo-Aczel S, Curry CJR, et al. PlasmaCarnitine deficiency: a clinical study of 51 pediatric patients. Am J Dis Child 1987; 141: 660-5. View abstract
Wu X, Huang W, Prasad PD, et al. Activity characteristics and tissue dispersion pattern set of organic cation/carnitine transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 1999; 290: 1482-92. view abstract
Zelnik N, Fridkis I, Gruener N. Carnitine and antiepileptic drug reduction: does it cause problems or coexistence? Acta Paediar 1995; 84: 93-5. view abstract
Zhang H, Kui Y, Dong L, Sun M, Zhang Y. Combination efficiency of l-carnitine L-acetylcarnitine in men with idiopathic oligoasterates pulmia: a periodic overview and meta-analysis. Andrologia. 2020; 52(2):E13470. abstract.
Source:
Retrieved from ” https: // variety-box. com. au/now-foods-aacetyl-l-carnitine-500-mg-100-veg-capsules-30098. html
Retrieved from ” https: // www. brainmirror. com/Notropics/acetyl-L-carnitine/
Retrieved from ” https: // www. webmd. com/vitamins/ai/gredientmon-834/acetyl-l-carnitineAbout Us
Family Medicine
In 2024 our team of doctors and nurses provide a comprehensive range of family planning services. Our doctors have expertise in antenatal care, preconception planning, and STD checks. Contraceptive advice including Mirena and Implanon insertion is available.- Early detection of illness;
- Family planning;
- Promotion of healthy lifestyle;
- Skin cancer checks;
- Sports injuries;
- Weight reduction;
- Workers compensation and third party.
- Cervical Screening tests;
- Reproductive health. Including Mirena and Implanon insertion;
- Shared antenatal care.
- Preventative Healthcare. Including cardiovascular screening, mental health and cancer checks;
- Prostate examination.
Children's Health
Baby Weighing Service. Babies can be booked with our Nurse for weighing, a doctors appointment is not required to use this service. Contact reception for a appointment to have your baby weighed.Immunisations. At Tuggeranong Square children's immunisation is regarded an important part of your childs health care. Our doctors take immunising children very seriously. and to ensure all children are immunised Tuggeranong Square Medical Practice doctors BULK BILL for all childhood immunisations. Tuggeranong Square Medical Practice also ensures the Practice Nursing Staff are highly trained in childhood immunisations.
Women's Health
Our practice is dedicated to treating a wide spectrum of women’s health concerns. We offer pre-natal, antenatal and postnatal care, contraceptive options, pap screening, and preventative health care advice. We provide assistance, advice and support through all stages of life, recognising the many issues many women may face from adolescence through to the peri and post-menopausal period.
Men's Health
We encourage men to present routinely to their GP to discuss all aspects of their health. We provide comprehensive advice and support for men to address the prevention and management of various health conditions. This may include assessments for cardiovascular risk, diabetes, cancer prevention, mental health assessments, STD screening, sports injuries and the importance of sleep as it relates to other areas of health.
